Advertising

PetMed Express: stocks, financial statements

Dividends News
Favorites

Markets prescription and non-prescription pet medications and other health products for dogs and cats

  • PETS Ticker
  • NASDAQ Exchange
  • 187 Employees
3 rated

Financial statements — PetMed Express

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
21 ← 16 2021 2020 2019 2018 2017 2016
Total Revenue
310M 280M 280M 270M 250M 230M
Cost Of Revenue
220M 200M 190M 180M 170M 160M
Gross Profit
90M 81M 95M 98M 79M 76M
Research and Development
0 0 0 0 0 0
Selling General and Admin
50M 48M 47M 44M 40M 43M
Operating Expense
270M 250M 240M 220M 210M 200M
Operating Income
38M 31M 46M 52M 37M 32M
Other Income Expense Net
0 0 0 0 0 0
EBIT
38M 31M 46M 52M 37M 32M
Interest Income
-310K -1.7M -1.9M -660K -140K -190K
Pretax Income
39M 34M 49M 54M 38M 33M
Income Tax
8.6M 8M 11M 17M 14M 12M
Minority Interest
0 0 0 0 0 0
Net Income
31M 26M 38M 37M 24M 21M
Net Income Basic
31M 26M 38M 37M 24M 21M
21 ← 16 2021 2020 2019 2018 2017 2016
Current cash
120M 100M 100M 78M 59M 38M
Short term investments
5.5M 3.4M 2M 1.7M 1M 2.7M
Receivables
2.6M 3.8M 2.5M 2.3M 1.8M 1.7M
Inventory
34M 18M 21M 23M 20M 26M
Other current assets
5.5M 3.4M 2M 1.7M 1M 2.7M
Current assets
160M 130M 130M 110M 82M 68M
Long term investments
26M 26M 28M 30M 31M 23M
Property plant equipment
25M 25M 27M 29M 30M 21M
Goodwill
0 0 0 0 0 0
Intangible assets
860K 860K 860K 860K 860K 860K
Other assets
0 0 0 0 0 0
Total assets
190M 160M 150M 130M 110M 90M
Accounts payable
40M 20M 16M 15M 15M 5M
Current long term debt
0 0 0 0 0 0
Other current liabilities
5.4M 4.7M 2.4M 2.8M 3.1M 2.1M
Total current liabilities
45M 24M 19M 18M 18M 7.1M
Long term debt
0 0 0 0 0 0
Other liabilities
0 0 0 0 0 0
Minority Interest
0 0 0 0 0 0
Total Liabilities
46M 25M 20M 19M 19M 7.1M
Common stock
20M 20M 20M 20M 20M 20M
Retained earning
130M 130M 120M 110M 87M 78M
Treasury stock
0 0 0 0 0 0
Capital surplus
Shareholder equity
140M 130M 130M 120M 93M 83M
Net tangible assets
140M 130M 130M 110M 92M 82M
21 ← 16 2021 2020 2019 2018 2017 2016
Net Income
31M 26M 38M 37M 24M 21M
Depreciation
2.4M 2.3M 2.2M 2.1M 1.4M 770K
Changes in receivables
-1.3M 1.3M 250K 480K 84K -210K
Changes in inventories
17M -3.5M -2M 3.1M -5.4M 520K
Cash change
15M 3.2M 23M 19M 21M -14M
Cash flow
40M 39M 45M 37M 47M 21M
Capital expenditures
-2.4M -2.3M -620K -700K -11M -20M
Investments
Investing activity other
Total investing cash flows
-2.4M -2.3M -620K -700K -11M -4.5M
Dividends paid
Net borrowings
-120M -110M -100M -80M -60M -40M
Other financing cash flows
Cash flow financing
-23M -33M -22M -17M -16M -15M
Exchange rate effect